Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
January 12, 2010

Roche Taps Kinaxo for Phosphoproteomics Technology

  • Kinaxo Biotechnologies will apply its phosphoproteomics technology PhosphoScout® to support targeted treatment approaches currently under development at Roche Diagnostics. PhosphoScout enables the identification of regulated protein phosphorylation sites in response to therapeutic antibody or kinase-inhibitor treatment, according to Kinaxo.

    Using quantitative mass spectrometry, up to 15,000 phosphorylation sites can be monitored in a single experiment, the company claims. This facilitates analysis of the phosphoproteome in patient samples, animal models, and cell culture on a global scale.

  • You’re all set! Thank you for subscribing to GEN Highlights.